home | search :  
email | print
Major Cases
  • Inter parties rexamination on behalf of Gladerma R&D of Leo Pharmaceutical Products Ltd., US Patent No. 6,753,013 for TACLONEX (August 2008)
  • The Pomeroy Collection, LTD. v. Kirkland’s Inc. & Home Essentials & Beyond, Inc., No. SACY 08-0635; AG (US Dist. June 13, 2008).
  • Pharm.Res., Inc. and Par Pharm., Inc. v. Roxane Labs., Inc., U.S. Court of Appeals for the Federal Circuit, 2007-1093, - 1134 (Fed. Cir. October 26, 2007).
  • In re Metoprolol Succinate Patent Litigation, No. 2006-1254 (Fed. Cir. July 23, 2007).
  • Westrex Corp. v. New Sensor Corp., 83 U.S.P.Q.2d 1215 (T.T.A.B. May 11, 2007).
  • Savient Pharmaceuticals, Inc. v. Sandoz, Inc., No. 2007-1081, 2007 U.S. App. LEXIS 2800, 2007 WL 419358 (Fed. Cir. Jan. 25, 2007) (order dismissing proceeding).
  • Pharm. Res., Inc. v. Roxane Labs. Inc., No. 03-3357, 2006 U.S. Dist. LEXIS 81628, 2006 WL 3231427 (D.N.J. Nov. 8, 2006).
  • Dey LP v. IVAX Pharm. Inc., 233 F.R.D. 567 (C.D. Cal. 2005).
  • Novartis Pharm. Corp. v. Eon Labs Mfg., Inc., 363 F.3d 1306 (Fed. Cir. 2004).
  • In re Les Halles De Paris J.V., 334 F.3d 1371 (Fed. Cir. 2003).
  • Nadel v. Isaksson, 321 F.3d 266 (2d Cir. 2003).
  • Well-Made Toy Mfg., Corp. v. Goffa Int'l Corp., 354 F.3d 112 (2d Cir. 2003).
  • Glaxo Wellcome Inc., v. Eon Labs Mfg., Inc., No. 00-Civ-9089, 2003 U.S. Dist LEXIS 14680, 2003 WL 22004874 (S.D.N.Y. Aug. 22, 2003).
  • In re Omeprazole Patent Litigation, 265 F. Supp. 2d 213 (S.D.N.Y. 2003).
  • Elite Licensing, Inc. v. Thomas Plastics, Inc., 250 F. Supp. 2d 372 (S.D.N.Y. 2003).
  • In re '639 Patent Litigation 154 F. Supp. 2d 157 (D. Mass. 2001), aff''d sub. nom. SmithKline Beecham Corp. v. Copley Pharm., No. 01-1611, 45 Fed. Appx. 915 (Fed. Cir. Aug. 15, 2002).
  • Well-Made Toy Mfg., Corp. v. Goffa Int'l Corp., 210 F. Supp. 2d 147 (E.D.N.Y. 2002).
  • Glaxo Wellcome Inc., v. Eon Labs Mfg., Inc., No. 00-Civ-9089, 2002 U.S. Dist. LEXIS 14950, 2002 WL 1874831 (S.D.N.Y. Aug. 13, 2002).
  • Bristol-Myers Squibb Co. v. Ben Venue Labs., Inc., 246 F.3d 1368 (Fed. Cir. 2001).
  • Nadel v. Play-By-Play Toys & Novelties, Inc., 208 F.3d 368 (2d Cir. 2000).
  • Ideal World Marketing Inc. v. Duracell Inc., 997 F. Supp. 334 (E.D.N.Y. 1998).
  • Valmet Paper Mach. Inc. v. Beloit Corp., 105 F.3d 1409 (Fed. Cir. 1997).
  • Thermalloy, Inc. v. Aavid Eng'g, Inc., 121 F.3d 691 (Fed. Cir. 1997).
  • Bayer AG v. Barr Laboratories, Inc., No. 92-Civ-0381, 1996 U.S. Dist. LEXIS 13032, 1996 WL 509714 (S.D.N.Y. 1996).
  • Glaxo Inc., Glaxo Group Limited, and Allen and Hanburys Limited v. Boehringer Ingelheim Corporation, and Boehringer Ingelheim Chemicals, Inc., 40 U.S.P.Q.2D 1848 (D.Conn. 1996).
  • Glaxo Inc., Glaxo Group Limited, and Hanburys Limited v. Boehringer Ingelheim Corporation and Boehringer Ingelheim Chemicals, Inc., 954 F. Supp. 469, 41 U.S.P.Q.2D 1445 (D.Conn. 1996).
  • Godinger Silver Art Co., Ltd. v. Int'l Silver Co. Inc., No. 95-Civ-9199, 1995 U.S. Dist LEXIS 17696, 1995 WL 702357 (S.D.N.Y. 1995).
  • Imperial Chem. Indus., PLC, v. Barr Labs., 795 F. Supp. 619 (S.D.N.Y. 1992).
  • Wallace Int'l Silversmiths, Inc. v. Godinger Silver Art Co., Inc., 916 F.2d 76 (2d Cir. 1990).